A core outcome set for clinical trials of Chinese medicine for hyperlipidemia: a study protocol for a systematic review and a Delphi survey

BACKGROUND: Hyperlipidemia, defined as elevated lipid levels, is the primary and major risk factor for atherosclerotic cardiovascular disease. Several studies have evaluated the effects of Chinese medicine (CM) on hyperlipidemia. However, due to the varied designs and methods of these studies, data...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Geng, Zhou, Li, Ouyang, Wenwei, Xuan, Meiling, Lu, Liming, Li, Xiaoyan, Wen, Zehuai, Chen, Xiankun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6322321/
https://www.ncbi.nlm.nih.gov/pubmed/30612586
http://dx.doi.org/10.1186/s13063-018-3082-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6322321/
https://www.ncbi.nlm.nih.gov/pubmed/30612586
http://dx.doi.org/10.1186/s13063-018-3082-9

Ejemplares similares